Surprising
A placebo-controlled trial found a yogurt bacterium significantly reduced gut symptom scores — and also linked it to better sleep and immune markers, though these extra findings come from a single early study.
This is among the first human trials on this specific probiotic strain, so while the gut symptom improvement is statistically significant, the broader claims about sleep and immunity are less certain and need independent replication.
In a placebo-controlled trial, people taking Lactobacillus bulgaricus LB42 reported fewer gastrointestinal symptoms, as measured by a standard rating scale. The same study also noted improvements in sleep quality and immune markers, but these additional benefits were not as rigorously confirmed and the study is among the first of its kind, so results should be treated as preliminary.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus bulgaricus LB42 for Improved Gastrointestinal Symptoms — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- 2026-01
- Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.